pandemic
Biotech firm Mabion said it had signed a deal with the US company for the ‘transfer of technology and technological trials in the manufacture of an antigen for Novavax's Covid-19 vaccine’.
Mabion press materials
Polish firm teams up with US pharmaceutical company to start producing coronavirus vaccine
